Mitral regurgitation (MR) is a serious but treatable form of heart valve disease (HVD). It is notoriously underdiagnosed and undertreated, which leads
to poor outcomes for patients and avoidable strain on services. This case study uses a fictional but realistic patient, Fatima, to compare typical care with an optimal care pathway for secondary MR. Her story illustrates how changes in the management and treatment of MR can help clinicians and commissioners improve the overall value and outcomes of the care pathway. It highlights the importance of early detection and treatment to enable patients to recover and live full and healthy lives.
The goal is to inspire more stakeholders to think strategically and collaboratively about engagement, education and designing optimal care pathways
for people with secondary MR.